Performance Compound

Anamorelin

Oral ghrelin-receptor agonist developed for cancer cachexia; approved in Japan as Adlumiz.

Scientific Overview

Anamorelin (ONO-7643) is an orally active selective ghrelin/GHSR-1a agonist. Approved in Japan (2021, Adlumiz, Ono Pharmaceutical) for cancer cachexia in NSCLC, gastric, pancreatic, and colorectal cancers. ROMANA-1/2 Phase 3 trials demonstrated lean-mass gains but failed handgrip-strength endpoints, leading to EMA refusal.

Key Research Benefits

  • Increases lean body mass
  • Improves appetite
  • Oral bioavailability

Potential Side Effects

Hyperglycemia
Nausea
Headache

Research Protocols

Common Dosages

Cachexia

100 mg
Daily, oral

Empty stomach 1h before food

Note: Dosages listed are common research protocols found in peer-reviewed literature and clinical trials. Individual results and requirements may vary significantly in a research context.

Dose Calculator

🧮 Peptide Reconstitution Calculator

mg

Total amount of peptide in the vial.

mL

Volume of water used to mix.

mcg

Draw to this mark

4000 Units

or 40.00 mL on a U-100 syringe

Concentration:2.50 mg/mL
Peptide per Unit:25.00 mcg/unit
*Always double-check your calculations. This tool is for educational purposes only.

Explore Anamorelin

Where to source

Vendors with public COAs that stock this category. Affiliate links are disclosed.

  • Limitless Life Nootropics
    FL-based research-peptide supplier with Janoshik third-party COAs and a public affiliate program at ~20%.
    COA: JanoshikAffiliate disclosed
  • SwissChems
    60+ peptide catalog with Janoshik COAs; weekly affiliate payouts.
    COA: JanoshikAffiliate disclosed
  • Amino Club
    EU/US-facing vendor with a 20% first-order / 10% recurring affiliate model.
    COA: Third-partyAffiliate disclosed

Stack Anamorelin with…

Curated stacking partners researched alongside Anamorelin. Each link opens a dedicated stack page with combined benefits, side-effect overlap, and half-life considerations.

Anamorelin by goal

Read Anamorelin's profile filtered through specific research goals.

Molecular Profile

small-molecule
C31H42N6O3
1 AA Sequence

Quick Reference

Status
Research Compound
Category
Performance
Common Dosage
100 mg
Daily, oral

Strictly for research purposes. Not for human consumption.

Medical Disclaimer

Information provided on DoseVault is for educational and research purposes only. This website does not advocate for the human use of peptides. Peptides are currently sold as research chemicals and are not FDA-approved for human consumption. Always consult a licensed medical professional before considering any protocol.